ADVITOS GmbH Tech Stack

CE-marked multi-organ support device for intensive care

Medical Device München, Bayern 51–200 employees Public Company

ADVITOS manufactures a patented medical device that simultaneously supports liver, lung, and kidney function in ICU patients—the only integrated multi-organ therapy of its kind. The company is scaling rapidly from a 20-hospital footprint in Germany toward international expansion, with support and healthcare staff comprising two-thirds of active hiring. The pain-point list reveals a classical MedTech bottleneck: clinical adoption is constrained by training burden, clinician-technologist alignment gaps, and deployment complexity—not by the technology itself.

Tech Stack 24 technologies

Core StackAdobe Creative Cloud Canva WordPress Figma Active Directory Intune Windows Server Linux VMware Hyper-V Excel Word PowerPoint LinkedIn Instagram Meta TikTok Microsoft Office Azure Entra Microsoft 365 Windows 11 Outlook Teams Adobe

What ADVITOS GmbH Is Building

◆Challenges

Communicating complex medical tech
Bridging clinician-technology communication
Training staff on new technology
Expanding device deployment
Building recruiting structures for growth
Growing it complexity
Optimizing product development processes
Cms optimization
Ensuring technology adoption in clinics
Staff training on new devices

▲Active Projects

Device deployment support
Ticket system optimization
Live support during therapy deployment
Training material development
Workshop organization
Mobile device management support
Social media campaign management
Marketing material creation
Event planning and execution
Recruiting process from idea to contract

Hiring Activity

Accelerating25 roles · 15 in 30d

Department

Support

Healthcare

Engineering

Logistics

Manufacturing

Marketing

Product

Seniority

Mid

Junior

Intern

Senior

Company intelligence

Find more companies like ADVITOS GmbH by tech stack, pain points and active projects

Get started free

About ADVITOS GmbH

ADVITOS develops the ADVOS system, a CE-marked and internationally patented medical device that provides simultaneous support to the liver, lungs, and kidneys in critically ill patients. The device eliminates water-soluble and protein-bound toxins while managing CO2 removal and acid-base balance through individual patient pH correction. Currently deployed across 20 leading university hospitals in Germany, ADVOS is expanding into international markets. The company operates with support-driven and clinician-facing operations, funded in part through EU Horizon 2020 grants.

HeadquartersMünchen, Bayern

Company Size51–200 employees

Hiring MarketsGermany

Frequently Asked Questions

What is ADVOS technology and how does it work?

ADVOS is a CE-marked, patented multi-organ support device that simultaneously supports liver, lung, and kidney function in ICU patients. It eliminates water-soluble toxins via kidney filtration, protein-bound toxins via liver and kidney support, and CO2 via lung support, while enabling patient-individual blood pH correction.

Where is ADVITOS deploying the ADVOS device?

ADVOS is currently used in intensive care units at 20 leading university hospitals throughout Germany and is actively expanding into international markets.